Advanced Biomed Inc Shareholders' Equity
Advanced Biomed Inc (ADVB) had Shareholders' Equity of $9.21 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-15
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.21M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.48M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.00M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $3.48M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-03-31 | $9.21M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $9.48M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $3.00M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $3.48M 10-Q · filed 2026-05-15 |
| 2025-03-31 | $4.13M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $619.03K 10-Q · filed 2026-02-13 |
| 2024-09-30 | $1.09M 10-Q · filed 2025-11-19 |
| 2024-06-30 | $1.66M 10-Q · filed 2026-05-15 |
| 2024-03-31 | -$497.80K 10-Q · filed 2025-05-15 |
| 2023-12-31 | $196.84K 10-Q · filed 2025-04-15 |
| 2023-06-30 | $1.31M 10-K · filed 2025-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |